Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions

Details for Australian Patent Application No. 2005245400 (hide)

Owner Bristol-Myers Squibb Company

Inventors Chao, Hannguang J.; Gungor, Timur; Tuerdi, Huji; Wang, Tammy C.; Qiao, Jennifer X.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005245400

PCT Pub. Number WO2005/113537

Priority 60/570,288 12.05.04 US; 11/126,567 10.05.05 US; 60/665,735 28.03.05 US

Filing date 11 May 2005

Wipo publication date 1 December 2005

International Classifications

A61K 31/444 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 209/14 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/96 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/06 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 241/42 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/113537 Priority application(s): WO2005/113537

8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005245401-Aryl sulfonamides

2005245399-CXCR1 and CXCR2 chemokine antagonists